A conditional mouse model for malignant mesothelioma

Johan Jongsma1, Erwin van Montfort, Marc Vooijs

  • 1Department of Molecular Genetics, Cancer Genomics Centre, Centre for Biomedical Genetics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Cancer Cell
|March 11, 2008
PubMed

Insights

Loss of Neurofibromatosis type 2 (NF2) and RB/P53 pathway genetic lesions contribute to malignant mesothelioma. Ink4a loss significantly worsens outcomes in mouse models, highlighting its role in this aggressive cancer.

Area of Science:

  • Oncology
  • Cancer Biology
  • Genetics

Background:

  • Malignant mesothelioma is a rare but aggressive cancer.
  • Loss of Neurofibromatosis type 2 (NF2) and genetic alterations in RB and P53 pathways are implicated in its development.
  • Understanding the genetic drivers is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of NF2, RB, and P53 pathway alterations in a murine model of malignant mesothelioma.
  • To compare the impact of different genetic lesions on mesothelioma development and progression.
  • To assess the contribution of Ink4a loss to tumor aggressiveness and patient survival.

Main Methods:

  • Creation of conditional knockout mouse models with specific genetic lesions (Nf2;Ink4a/Arf and Nf2;p53).
  • Induction of genetic alterations in the mesothelial lining of the thoracic cavity.
  • Monitoring tumor development, survival rates, and invasiveness in the mouse models.

Main Results:

  • Mesothelioma developed with high incidence in both Nf2;Ink4a/Arf and Nf2;p53 conditional knockout mice.
  • Murine mesothelioma models closely recapitulated human malignant mesothelioma characteristics.
  • Conditional Nf2;Ink4a/Arf mice exhibited increased pleural invasion compared to Nf2;p53 mice.
  • Loss of Ink4a in Nf2;p53 mice significantly reduced survival and increased tumor invasiveness.

Conclusions:

  • NF2 loss, combined with RB/P53 pathway inactivation, can induce malignant mesothelioma in mice.
  • Ink4a loss plays a critical role in promoting mesothelioma aggressiveness and poor clinical outcomes.
  • These findings provide valuable insights into mesothelioma pathogenesis and potential therapeutic targets.